Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Mathalon

Showing results (421-430 of 435) with videos related to

Pageof 44
Sort By:
Biorxiv : the Preprint Server for Biology|January 30, 2023
Normative modeling of brain morphometry in Clinical High-Risk for PsychosisShalaila S Haas, Ruiyang Ge, Ingrid Agartz, et al.
Schizophrenia Bulletin|May 11, 2026
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-SchizophreniaHenry R Cowan, Danielle Pratt, Jai L Shah, et al.
Schizophrenia (Heidelberg, Germany)|April 2, 2025
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia ProgramMichael P Harms, Kang-Ik K Cho, Alan Anticevic, et al.
Schizophrenia (Heidelberg, Germany)|March 25, 2025
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sampleKelly Allott, Walid Yassin, Luis Alameda, et al.
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
Shared genetic architecture of brain age gap across 30 cohorts worldwideVilte Baltramonaityte, Philippe Jawinski, Marlene Staginnus, et al.
Schizophrenia (Heidelberg, Germany)|June 6, 2025
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measuresDaniel H Mathalon, Spero Nicholas, Brian J Roach, et al.
Molecular Psychiatry|October 22, 2025
Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR StudySiwei Liu, Ingrid Agartz, Paul Allen, et al.
JAMA Psychiatry|May 5, 2021
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis, Maria Jalbrzikowski, Rebecca A Hayes, et al.
Biological Psychiatry|November 25, 2018
Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?Theo G M van Erp, Esther Walton, Derrek P Hibar, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2023
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortiumDick Schijven, Merel C Postema, Masaki Fukunaga, et al.
Pageof 44

Showing results (421-430 of 435) with videos related to

Sort By:
Pageof 44
Biorxiv : the Preprint Server for Biology|January 30, 2023
Normative modeling of brain morphometry in Clinical High-Risk for PsychosisShalaila S Haas, Ruiyang Ge, Ingrid Agartz, et al.
Schizophrenia Bulletin|May 11, 2026
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-SchizophreniaHenry R Cowan, Danielle Pratt, Jai L Shah, et al.
Schizophrenia (Heidelberg, Germany)|April 2, 2025
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia ProgramMichael P Harms, Kang-Ik K Cho, Alan Anticevic, et al.
Schizophrenia (Heidelberg, Germany)|March 25, 2025
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sampleKelly Allott, Walid Yassin, Luis Alameda, et al.
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
Shared genetic architecture of brain age gap across 30 cohorts worldwideVilte Baltramonaityte, Philippe Jawinski, Marlene Staginnus, et al.
Schizophrenia (Heidelberg, Germany)|June 6, 2025
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measuresDaniel H Mathalon, Spero Nicholas, Brian J Roach, et al.
Molecular Psychiatry|October 22, 2025
Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR StudySiwei Liu, Ingrid Agartz, Paul Allen, et al.
JAMA Psychiatry|May 5, 2021
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis, Maria Jalbrzikowski, Rebecca A Hayes, et al.
Biological Psychiatry|November 25, 2018
Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?Theo G M van Erp, Esther Walton, Derrek P Hibar, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2023
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortiumDick Schijven, Merel C Postema, Masaki Fukunaga, et al.
Pageof 44